Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs (MAS-I)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02320994|
Recruitment Status : Completed
First Posted : December 19, 2014
Last Update Posted : November 29, 2018
In this first step of the study the investigators will assess the needs, disease burden and current treatments of long-term stroke patients (phase MAS-I).
The ultimate aim of the complete MAS project (MAS I, II & III) is the development of a model of stroke aftercare delivery that can be evaluated to estimate effects in both our local and the wider stroke population.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||64 participants|
|Official Title:||Managing Aftercare for Stroke (MAS): MAS-I - a Cross Sectional Study of Post-rehabilitation Stroke Burden and Patients' Needs|
|Study Start Date :||November 2014|
|Actual Primary Completion Date :||December 2015|
|Actual Study Completion Date :||December 2015|
post-rehabilitation stroke patients
- Prevalence of unmet Needs [ Time Frame: once ]Unmet needs of patients and carers after discharge from Rehabilitation. Score of variables examined (self-reported stroke related need, post-stroke spasticity, post-stroke pain, post-stroke aphasia, neuropsychological impairment, post-stroke depression, post-stroke dementia, inadequate secondary prevention, social care need and carer burden).
- post-stroke checklist [ Time Frame: once ]Evaluation of post-stroke checklist as a valid tool to screen for relevant burden of disease after stroke.
- Standard practice evaluation [ Time Frame: once ]Comparison of Standard practice in relation to evidence-based recommendations and current Clinical Guidelines for the management of stroke.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02320994
|Charité - Universitätsmedizin Berlin (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center)|
|Berlin, Germany, 10117|
|Principal Investigator:||Andreas Meisel, Prof. Dr. med.||Charité - Universitätsmedizin Berlin, NeuroCure Clinical Research Center & Center for Stroke Research Berlin|
|Principal Investigator:||Ian Wellwood, Prof. Dr.||Charité - Universitätsmedizin Berlin, Center for Stroke Research Berlin (CSB)|
|Principal Investigator:||Jörg Wissel, Prof. Dr.||Neurologie und Psychosomatik am Wittenbergplatz|